John Simard - Mar 17, 2025 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
John Simard
Stock symbol
XBIT
Transactions as of
Mar 17, 2025
Transactions value $
$0
Form type
4
Date filed
3/19/2025, 03:03 PM
Previous filing
Feb 4, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIT Stock Option Award $0 +1.03M +117.91% $0.00 1.9M Mar 17, 2025 Common Stock 1.03M $3.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 17, 2025 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options vested immediately on the Grant Date.